Abstract The short-term surgical results for mixed aortic valve disease (MAVD) and the long-term effects on the left ventricle (LV) are unknown. Retrospective review identified patients with at least both moderate aortic stenosis (AS) and aortic regurgitation (AR) before surgical intervention. A one-to-one comparison cohort of patients with MAVD not referred for surgical intervention was identified. The 45 patients in this study underwent surgical management for MAVD. A control group of 45 medically managed patients with MAVD also was identified. Both groups had elevated LV end-diastolic volume (EDV), elevated LV mass, a normal LV mass:volume ratio (MVR), and a normal ejection fraction. Both groups had diastolic dysfunction shown by early diastolic pulsed-Doppler mitral inflow/early diastolic tissue Doppler velocity z-score. The LV end-diastolic pressure (EDP) was correlated with age (R = 0.4; p = 0.03) and LV MVR (R = 0.4; p = 0.03) but not with AS, AR, or the score combining gradient and LV size. As shown by 6-to 12-month postoperative echocardiograms, aortic valve gradients and AR significantly improved (gradient 65 ± 17 to 28 ± 18 mmHg, p = 0.01; median regurgitation grade moderate to mild; p \ 0.01), LV EDV normalized, and LV mass significantly improved (p \ 0.01). Diastolic dysfunction was unchanged. Symptoms did not correlate with any measured parameter, but the preoperative symptoms resolved. In conclusion, despite diastolic dysfunction, systolic function is invariably preserved, and symptoms are not correlated with aortic valve function or LV EDP. Current surgical practice preserves LV mechanics and results in short-term improvement in valve function and symptoms.
Introduction
Mixed aortic valve disease (MAVD), composed of both aortic stenosis (AS) and regurgitation (AR), is a rare primary disorder. In some patients, MAVD develops as a long-term consequence of the catheterization and surgical management of critical AS or surgery for AR [1, 4, 9, 12, 21, 23, [25] [26] [27] . Given that these procedures began in the 1980s, the population of patients with MAVD is growing yet significantly understudied. The effects of MAVD on the left ventricle (LV) differ from those of pure AS or AR. In MAVD, the LV end-diastolic dimension is smaller than in pure AR and larger than in pure AS [4, 27] . The LV shortening fraction is lower in MAVD patients than in pure AS patients [25] .
Although Zilberszac et al. [35] shed light on the natural history of MAVD in adults, the current management and timing of surgical aortic valve repair in children are idiosyncratic due to the lack of understanding concerning the unnatural history and effects of MAVD on LV mechanics. This report characterizes the effects of surgery on valve performance and LV function.
Methods
We retrospectively reviewed all patients who had received an echocardiogram with MAVD from January 2003 to September 2011 and had undergone surgery for MAVD. For this study, MAVD was defined as at least moderate AS (either apical maximal instantaneous gradient or suprasternal notch mean gradient C36 mmHg depending on which had a better angle of interrogation or a better Doppler envelope) and moderate AR (vena contracta C3.1 mm/body surface area [BSA] 0.5 or a descending aortic Doppler profile with holodiastolic flow reversal) [5] . The exclusion criteria ruled out other significant structural heart disease (residual mitral stenosis, residual coarctation, or complex congenital heart disease).
A control group of the 45 most recent medically managed patients with MAVD was identified. These patients may have had prior surgery for isolated AS or AR but had not been referred to undergo surgery for MAVD. Echocardiograms from the preoperative, inpatient postoperative, and 6-to 12-month postoperative periods were included as well as the most recent echocardiograms for medical patients.
The following variables were recorded from each echocardiogram: age, BSA, indexed LV end-diastolic volume (EDV)/BSA, LV EDV z-score, LV mass z-score, ejection fraction (EF), fractional shortening, LV mass:volume ratio (MVR), LV MVR z-score, AS grade, aortic valve gradient, and AR grade. The aortic valve gradient was defined as the higher number between the maximal instantaneous gradient across the aortic valve from the apical view and the mean gradient from the suprasternal notch view [34] . The LV volumes were calculated using the 5/6-area-length method [24] .
Diastolic function was assessed using pulsed-Doppler of the mitral peak early (E) and peak late (A) inflow velocities and tissue Doppler imaging (TDI). Pulsed-wave TDI velocities (peak early diastolic velocity [E 0 ], and peak late diastolic velocity [A 0 ]) were measured from the lateral mitral annulus and the interventricular septum from the apical four-chamber view. Conventional indices of diastolic function were calculated including mitral valve peak E and A velocities, the E:A ratio, the E-wave deceleration time, and the E/E 0 ratio. Echocardiographic parameters were converted to z-scores as recommended by the American Society of Echocardiography [24] using normative data developed at Boston Children's Hospital [16, 32] .
Primary disease process or processes, intervention history, gender, New York Heart Association (NYHA) functional or modified Ross heart failure (for preverbal children) classification, and transplantation/death were recorded. A NYHA functional classification or a modified Ross heart failure classification of 2 or higher was considered symptomatic. Preoperative LV end-diastolic pressure (EDP) was recorded when available. The study was approved by the Department of Cardiology Scientific Review Committee and the Boston Children's Hospital Committee on Clinical Investigation.
Statistical Analysis
Sample size was estimated to detect changes in LV EF and LV mass z-score between preoperative and 6-to 12-month postoperative echocardiograms. Calculations assumed paired, two-sided tests of means conducted at a 0.05 significance level and 90 % power. Assuming a standard deviation for a change in LV EF of 12 % [11, 33] , 24 patients would be required to detect an 8 % difference. Assuming a standard deviation for a change in LV mass z-score of 2.1 [4] , 47 patients would be needed to detect a mean difference of 1.0.
Continuous variables were reported as mean ± standard deviation for normally distributed variables and as median (interquartile range) for non-normally distributed data. Categorical variables were reported as frequency (%). Variables were compared with the paired t test for the preand postoperative echocardiograms and with the unpaired t test for the surgical versus medical patients. Baseline patient characteristics were compared for medical and preoperative surgical patients using Fisher's exact test or Wilcoxon rank sum test. Pearson correlation coefficients linked LV EDP and echocardiographic data. Analyses were performed with SPSS 16.0 (SPSS, Inc., Chicago, IL, USA) and STATA 11 (STATA Corp., College Station, TX, USA).
Results

Patient Characteristics
From January 2003 through September 2011, 45 patients underwent surgery for at least moderate MAVD. Most of the patients (62 %) underwent surgical valvuloplasty/ repair, whereas fewer underwent aortic valve replacement (AVR) (27 %) or Ross procedure (11 %). Table 1 shows the demographic and clinical data. Most of the patients in both groups had isolated aortic valve disease and previous catheterization balloon dilations but no previous surgery. For 8 surgical and 12 medical patients, no previous aortic valve interventions had been performed. Compared with the medically managed patients, those who underwent surgery were younger (p \ 0.01), had a history of more aortic valve surgeries (p = 0.04), and were more likely to be symptomatic with worsening NYHA functional or modified Ross heart failure classification (p = 0.02), as shown in Fig. 1 .
Echocardiographic Data
The echocardiographic variables are shown in Tables 2 and  3 . Compared with the medically managed patients, the surgical patients had higher LV EDV z-scores (3.5 ± 2.5 vs. 2.5 ± 1.6; p = 0.05) and higher valve gradients (65 ± 17 vs. 55 ± 17; p = 0.01) preoperatively. The LV MVR z-score was preserved in both groups (z-scores, 1.8 ± 4.6 and 1.1 ± 2.5, respectively). For the surgical patients, the 6-to 12-month postoperative echocardiograms showed significant improvement in indexed LV EDV, LV EDV z-score, aortic valve gradient, and AR grade. The LV MVR z-score remained normal after surgery. Although the 
Mild mitral stenosis or regurgitation 3 (7) 0 (0)
Coronary anomalies 3 (7) 0 (0)
Native aortic valve morphology 0.20
16 (35) 12 (27) Bicuspid (right nonfusion) 13 (29) 10 (22) Bicuspid (left nonfusion)
Tricuspid 3 (7) 1 (2) Previous aortic valve interventions CoA Coarctation of the aorta, VSD ventricular septal defect, PDA patent ductus arteriosus, NYHA New York Heart Association decrease in LV EF was significant (68 ± 7 vs. 62 ± 5; p \ 0.01), no patient had an LV EF lower than 55 % on his or her 6-to 12-month postoperative echocardiogram.
Diastolic Function
Of the 45 surgical patients, 22 (49 %) had preoperative catheterizations, whereas 8 (18 %) of the medical patients had catheterizations. The findings showed that LV EDP was positively correlated with the E/E 0 z-score (R = 0.51; p = 0.02), age (R = 0.37; p = 0.05), and the LV MVR z-score (R = 0.41; p = 0.03) (Fig. 2) . Furthermore, LV EDP tended to be normal before the age of 14 years and abnormal after the age of 16 years. The echocardiographic diastolic assessment showed a correlation of LV EDP with the E/E 0 z-score (R = 0.51; p = 0.02; Fig. 2 ) and the mitral inflow E-wave deceleration time z-score (R = -0.43; p = 0.04). Diastolic function, measured by E/E 0 z-score, did not change postoperatively.
Symptoms
In the intervention group, 14 patients (31 %) were symptomatic, with the majority categorized as NYHA or modified Ross heart failure class 2. Only three patients (7 %) were categorized as class 3. The medical group had only six symptomatic patients (13 %), all of whom were categorized as NYHA or modified Ross heart failure class 2.
The age distribution of symptoms is shown in Fig. 3 . All the symptomatic patients were older than 8 years. Figure 4 depicts subanalyses of patients dichotomized by symptoms.
The symptoms did not correlate with LV EDP, E/E 0 z-score, aortic valve gradient, or AR. Despite the lack of hemodynamic correlation, the symptomatic patients were more likely to undergo surgery than the asymptomatic patients (p = 0.02).
Discussion
In the young, MAVD is rare in the absence of prior procedures to palliate that valve. However, the increased use of catheterization or surgery to improve (rather than replace) markedly abnormal aortic valves is causing this patient population to expand rapidly [1, 3, 9, 27] . Although we and others have recognized this trend, a comprehensive description of the clinical and physiologic characteristics of these patients remains, to our knowledge, unreported.
The primary findings of this study are as follows:
1. Symptoms have no correlation with severity of aortic valve dysfunction or LV EDP. 2. Left ventricular (LV) systolic function is preserved in all patients, both with and without surgical management. 3. Diastolic dysfunction is common and increases with patient age but seems unrelated to the severity of valve dysfunction, although our measure of valve dysfunction severity captured only one moment in time, as opposed to the cumulative burden of disease. 4. Surgical management, generally valve repair, improves valve function, reduces LV volume and mass, and improves NYHA functional or modified Ross heart failure classification grade.
Symptoms
Adults with chronic AR tend to be asymptomatic for a long time [22] . Once symptoms begin, LV EF and survival decrease dramatically [7, 15] . This has led to adult clinical practice guidelines including symptoms as an indication for surgery [20] . Our data show that symptoms in children with MAVD tend to occur in later childhood and would be interesting to track with formal exercise testing. According to the data, symptoms do not correlate with severity of aortic valve dysfunction, systolic function, or diastolic dysfunction. Although this brings symptoms into question as an indication for surgery in MAVD, symptoms resolve postoperatively, and we lack longitudinal outcome data for patients who do not undergo surgery.
Systolic Function
The adult experience with AVR has shed light on some predictors of LV systolic function recovery. Adults with chronic AR tend to have full recovery of systolic function by 6 months after AVR [10] . In those patients who have not recovered by 6 months after AVR, the LV tends not to recover [6] . We also noted normalization of LV dilation and near normalization of LV mass during the 6-to 12-month follow-up period. In adults, preoperatively indexed LV size in systole and diastole were independent predictors of restored LV function [8, 10] . Similarly, for adults with severe AS who had an AVR, a smaller preoperative LV EDV was a predictor of better postoperative LV functional recovery [14, 31, 33] .
In our surgical cohort, the preoperative LV EF was preserved and remained normal postoperatively for all the patients. Although practitioners may have chosen surgical intervention before a significant decrease in LV EF, it is reasonable to assume that in the early stages of MAVD, LV EF is an insensitive marker of LV dilation, elevated filling pressures, or higher degree of valve dysfunction. Comparison between medical and surgical preoperative echocardiograms à Comparison between surgical preoperative and 6-to 12-month postoperative echocardiograms § Regurgitation (AR) grading system: 0 = none/trivial, 1 = mild, 2 = moderate, 3 = severe Mitral inflow E-wave decel time z-score -0.3 ± 1.3 -0.1 ± 1.7 -0.2 ± 1.0 0.62 0.91
Mitral annular E 0 (cm/s) 13.5 ± 3.3 12.9 ± 3.1 13.4 ± 3.3 0.46 0.65
Mitral annular E 0 z-score -1.8 ± 1.0 -1.7 ± 1.1 -1.7 ± 1.0 0.82 0.89
Septal E 0 (cm/s) 9.8 ± 2.4 9.5 ± 3.0 9.0 ± 2.0 0.72 0.78
E/E 0 ratio z-score 3.5 ± 4.2 3.9 ± 2.6 3.4 ± 1.6 0.08 0.61
Values are expressed as mean ± standard deviation E Pulsed Doppler mitral inflow peak E-wave velocity, A pulsed Doppler mitral inflow peak A-wave velocity, decal deceleration, E 0 , tissue Doppler mitral inflow peak E-wave velocity *Echocardiographic evaluation 6-12 months after surgery
Comparison between medical and surgical preoperative echocardiograms à Comparison between surgical preoperative and 6-to 12-month postoperative echocardiograms Diastolic Function Diastolic dysfunction as measured by E/E 0 z-score was present in most of the patients in our study and correlated with LV EDP. No significant change in E/E 0 z-score was observed 6-12 months after surgery. We do not have invasive late postoperative assessments of LV EDP to correlate these findings.
Other studies have shown that diastolic dysfunction is present in patients with congenital AS and that it recovers after the outflow tract obstruction is relieved [13, 17, 18, 28] . Some anecdotal data also have suggested that severe diastolic dysfunction is seen late after aortic valve balloon dilation in infancy [30] . Diastolic dysfunction is present in AS and MAVD patients more than in pure AR patients and is associated with a higher LV mass z-score [19] . Our data suggest that in the MAVD population, diastolic dysfunction may take longer to recover than LV mass or volume because it persisted 6 to 12 months postoperatively. We also found that LV EDP is unrelated to valve function but related to age. Before the age of 14 years, LV EDP generally is normal, whereas after the age of 16 years, LV EDP tends to be increased.
Surgical Management
Referral to surgery in this patient population was idiosyncratic and not based on any set criteria because few, if any, data existed that might have informed indications for surgery in children. However, referral was not totally random. Patients undergoing surgery had higher aortic valve gradients, higher degrees of AR, and an increased prevalence of symptoms. Our current idiosyncratic strategy for surgical intervention resulted in short-term valve function improvement and recovery of LV size and LV mass.
Our findings of LV recovery after surgical intervention for MAVD are similar to data from other studies investigating different types of aortic valve disease. Bacha et al. [3] described outcomes for patients with a history of congenital AS status after balloon dilation who subsequently experienced the development of predominant AR. In this population, LV dilation and the amount of AR both decreased after surgical repair and remained reduced over time.
In our population of MAVD patients, we found a similar recovery in LV EDV after surgical intervention. In another population of patients with predominant AR, freedom from AVR was 72 % at 5 years and 54 % at 7.5 years and shorter in the MAVD patients than in the pure AR Patients [4] . On the other hand, among the patients who had undergone a Ross procedure, those with MAVD had 10 years of freedom from reoperation, similar to those who had pure AS (97 and 93 %, respectively) and longer than those who had pure AR (69 %) [2] . The high rate of freedom from reoperation is consistent with our finding of overall significant LV recovery after surgery for MAVD.
Study Limitations
The limitations of this study included its retrospective design, small number of patients, and variability in patient characteristics. Not all the patients had catheterizations. The lack of clinical guidelines for determining when to catheterize and when to refer for surgical intervention on the aortic valve made practice variation substantial between practitioners and over time. The contribution of the placebo effect to improvement of symptoms postoperatively could not be assessed. Many patients were primarily followed at other institutions. Thus, the echocardiogram protocols differed, and some data, including duration of the MAVD burden, were unavailable. Longer-term follow-up evaluation would clarify the course of diastolic dysfunction and patient outcomes, which in turn could shed light on the timing of surgical intervention for MAVD.
Conclusion Surprisingly, MAVD is well tolerated at least for the first two decades of life. Postoperative recovery in terms of clinical status as well as LV volume, mass, and valvar function is encouraging. Given the current idiosyncratic management strategies, EF is preserved in MAVD patients and thus is not helpful in determining disease severity or optimal operative timing. Diastolic dysfunction progresses with age in MAVD patients and does not recover in the immediate postoperative period. Further investigation of the outcomes for patients with diastolic dysfunction will aid in determining optimal surgical timing. Because MAVD is infrequent, a standardized and systematic approach to preoperative assessment and surgical management with targeted prospective data collection and frequent analyses may speed the generation of persuasive data [29] .
